Refractory Medulloblastoma: Clinical Trials

6 trials for Refractory Medulloblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 active not recruiting, 1 completed. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Recruiting 3, Active not recruiting 2, Completed 1
Phase 22Completed 1, Recruiting 1

Follow Refractory Medulloblastoma: new trials by email Literature Review of Refractory Medulloblastoma trials Research Report on Refractory Medulloblastoma

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
25 mCi 177Lu- DTPA-omburtamab - Recurrent Medulloblastoma, Refractory Medulloblastoma
Phase 1RecruitingMemorial Sloan Kettering Cancer Center242026-07-022026-10-08
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
GPC2-CAR T cells, Fludarabine, Cyclophosphamide - Medulloblastoma, Central Nervous System Embryonal Tumor
Phase 1RecruitingStanford University182025-08-282026-10-09
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
LUTATHERA® (Lutetium Lu 177 dotatate) - High Grade Glioma, Meningioma
Phase 1 / Phase 2RecruitingNationwide Children's Hospital652022-11-212026-11-16
Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
Biospecimen Collection, Magnetic Resonance Imaging, Savolitinib - Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Malignant Glioma
Phase 1Active not recruitingNational Cancer Institute (NCI)412018-11-272026-07-30
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Biospecimen Collection, Conventional Magnetic Resonance Imaging, Diffusion Tensor Imaging - Constitutional Mismatch Repair Deficiency Syndrome, Lynch Syndrome
Phase 1Active not recruitingNational Cancer Institute (NCI)712015-06-032026-07-20
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Adavosertib, Irinotecan Hydrochloride - Central Nervous System Embryonal Tumor With Rhabdoid Features, Central Nervous System Embryonal Tumor, Not Otherwise Specified
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)762014-03-282023-09-26

Narrower conditions

Medulloblastoma (6)  ·  Central Nervous System Neoplasms (3)  ·  Diffuse Intrinsic Pontine Glioma (3)  ·  Glioma (3)  ·  Brain Neoplasms (2)  ·  Ependymoma (2)  ·  Neuroectodermal Tumors, Primitive (2)  ·  Pinealoma (2)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (1)  ·  Familial ependymoma (1)  ·  Meningioma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neuroblastoma (1)  ·  Rhabdoid Tumor (1)  ·  Rhabdomyosarcoma (1)

Broader conditions

Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Neoplasms, Nerve Tissue (6)  ·  Neoplasms, Neuroepithelial (6)  ·  Neuroectodermal Tumors (6)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Nervous System Diseases (5)  ·  Nervous System Neoplasms (5)  ·  Neuroectodermal Tumors, Primitive (4)  ·  Brain Neoplasms (3)  ·  Brain Stem Neoplasms (3)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine (1)  ·  Cyclophosphamide (1)  ·  Diffusion Tensor Imaging (1)  ·  Irinotecan (1)  ·  Phantoms, Imaging (1)  ·  X-Rays (1)  ·  adavosertib (1)  ·  fludarabine (1)  ·  lutetium Lu 177 dotatate (1)  ·  pembrolizumab (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Nationwide Children's Hospital (1)  ·  Stanford University (1)

Countries

United States (6)  ·  Canada (3)

Top investigators

Eugene I Hwang (1)  ·  Katherine Ryan, DO (1)  ·  Kristina A Cole (1)  ·  Margot Lazow, MD (1)  ·  Ralph Salloum (1)  ·  Sameer Farouk Sait, MBBS (1)

NIH funding

UM1CA081457 (2), UM1CA097452 (1)